Literature DB >> 10568702

Gestational exposure to chlorpyrifos: dose response profiles for cholinesterase and carboxylesterase activity.

T L Lassiter1, S Barone, V C Moser, S Padilla.   

Abstract

This study investigates the in vivo dose response profiles of the target enzyme cholinesterase (ChE) and the detoxifying enzymes carboxylesterase (CaE) in the fetal and maternal compartments of pregnant rats dosed with chlorpyrifos [(O,O'-diethyl O-3,5,6-trichloro-2-pyridyl) phosphorothionate], a commonly used organophosphorus insecticide. Pregnant rats were dosed daily (po) with chlorpyrifos in corn oil (0, 3, 5, 7, or 10 mg/kg) on gestational days (GD) 14-18. Animals were sacrificed 5 h after the last chlorpyrifos dose (time of maximum brain cholinesterase inhibition) for analysis of ChE and CaE activity in maternal blood, liver, brain, placenta, and fetal liver and brain. The in vitro sensitivity (i.e., IC50, 30 min, 26 degrees C) of CaE also was determined by assaying the activity remaining after incubation with a range of chlorpyrifos-oxon concentrations. In vivo exposure to 10 mg/kg chlorpyrifos from GD14-18 caused overt maternal toxicity, with dose-related decreases in ChE activity more notable in maternal brain than fetal brain. Dose-related effects were also seen with chlorpyrifos-induced inhibition of fetal liver ChE and maternal brain CaE activities. Gestational exposure caused no inhibition of placental ChE or CaE, fetal brain CaE, or maternal blood CaE. ChE activities in the maternal blood and liver, as well as fetal and maternal liver CaE, however, were maximally inhibited by even the lowest dosage of chlorpyrifos. The in vitro sensitivity profiles of CaE to chlorpyrifos-oxon inhibition were valuable in predicting and verifying the in vivo CaE response profiles. Both the in vivo and in vitro findings indicated that fetal liver CaE inhibition was an extremely sensitive indicator of fetal chlorpyrifos exposure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10568702     DOI: 10.1093/toxsci/52.1.92

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  7 in total

Review 1.  Evaluation of epidemiology and animal data for risk assessment: chlorpyrifos developmental neurobehavioral outcomes.

Authors:  Abby A Li; Kimberly A Lowe; Laura J McIntosh; Pamela J Mink
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2012       Impact factor: 6.393

2.  A comparison of neurotoxicity in cerebellum produced by dermal application of chlorpyrifos in young and adult mice.

Authors:  K Krishnan; N K Mitra; L S Yee; H M Yang
Journal:  J Neural Transm (Vienna)       Date:  2011-09-16       Impact factor: 3.575

3.  Uptake of dietary retinoids at the maternal-fetal barrier: in vivo evidence for the role of lipoprotein lipase and alternative pathways.

Authors:  Lesley Wassef; Loredana Quadro
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

Review 4.  Predicting Human Fetal Drug Exposure Through Maternal-Fetal PBPK Modeling and In Vitro or Ex Vivo Studies.

Authors:  Ankit Balhara; Aditya R Kumar; Jashvant D Unadkat
Journal:  J Clin Pharmacol       Date:  2022-09       Impact factor: 2.860

Review 5.  Pesticide exposure and neurodevelopmental outcomes: review of the epidemiologic and animal studies.

Authors:  Carol J Burns; Laura J McIntosh; Pamela J Mink; Anne M Jurek; Abby A Li
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2013       Impact factor: 6.393

6.  Non-invasive saliva human biomonitoring: development of an in vitro platform.

Authors:  Thomas J Weber; Jordan N Smith; Zana A Carver; Charles Timchalk
Journal:  J Expo Sci Environ Epidemiol       Date:  2015-11-11       Impact factor: 5.563

7.  Characterization of placental cholinesterases and activity induction associated to environmental organophosphate exposure.

Authors:  S Sánchez; B Vera; C Montagna; G Magnarelli
Journal:  Toxicol Rep       Date:  2014-11-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.